Monday.com Faces Legal Deadline, but Real Catalyst Is 2026 Guidance Risk

The class action lawsuit filed on March 21, 2026, is a direct legal consequence of a severe business deterioration, not a standalone catalyst. It targets stock purchases made between September 17, 2025, and February 6, 2026-a period that captures the stock's most violent declines. The lawsuit itself is a secondary event, a legal aftermath of the core business problems that drove investors out.

The first major crack appeared on November 10, 2025. After reporting Q3 results, the stock fell 12.3% on the news that the company expected only a "comparatively modest increase" in Q4 revenue, despite maintaining a lofty $1.8 billion by fiscal year '27 target. That guidance miss was the initial red flag. The situation worsened dramatically in February. On February 9, 2026, after releasing Q4 results, monday.com did the unthinkable: it rescinded its $1.8 billion 2027 revenue target and guided for a "significant deceleration" in growth. The stock responded with another 20.8% plunge, hitting multi-year lows and losing three-quarters of its value over the past 12 months.

The lawsuit, filed just days after that catastrophic February drop, alleges the company misled investors about decelerating customer growth and inadequate AI investments throughout that same volatile period. In essence, the legal action is a formal accusation that the company's public statements during its freefall were materially false. The key point for investors is that the stock's severe drop suggests the primary risk-the deterioration of its growth trajectory and valuation-is already priced in. The lawsuit is a symptom of that pain, not the source.

The Core Disconnect: Strong Metrics vs. Weak Guidance

The lawsuit alleges that monday.com misled investors about its revenue outlook. Yet the market's violent reaction was a direct response to the company's own weak forward guidance, not a hidden problem uncovered by the legal action. The disconnect lies in what the stock is pricing: future growth fears, not past operational misstatements.

The core event was the February 9 earnings report. Despite the company delivering strong financial results in 2025 with 25% year-over-year revenue growth in Q4, the stock fell another 20.8%. The reason was the guidance that followed. Management rescinded its $1.8 billion 2027 target and signaled a "significant deceleration" in growth for 2026. That forward-looking statement, not any alleged past misrepresentation, triggered the collapse. The lawsuit's focus on past revenue outlooks seems to miss the immediate catalyst.

Analysts had already flagged the setup. Before the report, BofA Securities cited a "challenging setup" and "intensifying AI fears" as key concerns, specifically warning that the company might provide 2026 guidance below Street estimates. The firm lowered its price target to $157 on January 29, well before the lawsuit was filed. This shows the market was pricing in a growth scare long before the legal action.

The numbers themselves tell a nuanced story. The company did report solid growth, with 28.6% revenue growth over the last twelve months. The lawsuit's allegation that customer growth was decelerating is a claim about the future, not a revelation about the past quarter's performance. The market's reaction was a bet on that future deceleration, which the February guidance confirmed.

The bottom line is that the lawsuit is a symptom of a valuation reset already in motion. The stock's collapse reflects a loss of confidence in the growth trajectory, not a discovery of fraud. For the lawsuit to be material, it would need to prove that the company's past statements were materially false and that those falsehoods caused the drop. But the drop was caused by the company's own subsequent, self-acknowledged guidance miss. The legal action may create noise, but it doesn't change the fundamental market view that growth is slowing.

Valuation Context: A Stock Near Its Floor

The stock's current price of around $74 places it well below its 52-week low of $123.45, suggesting that the most severe downside risk is already priced in. The tactical opportunity here hinges on distinguishing between a known, time-bound legal event and the ongoing, open-ended business uncertainty that drove the decline.

The primary financial risk is not the lawsuit. It is the company's ability to meet or exceed Street estimates for 2026 growth, which are projected at 21%. This is the core of the "challenging setup" BofA Securities identified. The firm expects management to take a conservative stance, with high-teens growth guidance more likely. Any guidance that falls short of the 21% estimate would likely trigger another sell-off, while a beat could spark a rebound. The lawsuit deadline for lead plaintiff status on May 11, 2026, creates a near-term catalyst for settlement talks or trial scheduling. But this is a known event with a fixed timeline, unlike the fluid business risk.

Viewed another way, the legal action is a distraction from the real valuation question. The stock's collapse from its highs to these lows reflects a loss of confidence in the growth trajectory, not a discovery of fraud. The lawsuit alleges past misstatements, but the market's violent reaction was a direct response to the company's own subsequent guidance miss. For the lawsuit to materially impact the stock, it would need to prove those past statements caused the drop. That's a high bar when the drop was caused by the company's own subsequent, self-acknowledged problems.

The bottom line is a clear risk/reward split. The legal risk is a time-bound event with a May 11 deadline. The business risk-the path to 2026 growth-is the ongoing uncertainty. The stock's deep discount to its recent lows offers a potential margin of safety, but only if the company can navigate the "wall of worry" and deliver on the conservative growth path that analysts now expect.

Immediate Tactical Catalysts

The path forward hinges on two distinct sets of events. The legal timeline is fixed. The deadline for investors to file for lead plaintiff status in the class action lawsuit is May 11, 2026. This date could trigger settlement announcements or trial scheduling. While a legal resolution would remove a source of uncertainty, the market has already priced in the core business deterioration. Any settlement would likely be a fraction of the stock's losses, making the legal event a distraction from the real valuation question.

The true catalysts are business events. The first is any 2026 revenue guidance from management. The setup is clear: analysts expect the company to take a conservative stance, with high-teens growth guidance more likely than the Street's 21% estimate. BofA Securities described this as a "challenging setup". The next major test is the upcoming Q1 2026 earnings report. The stock's reaction to that release will be a direct signal of stabilization or further deterioration. A beat on conservative expectations could spark a rebound, while another miss would likely trigger another sell-off.

The bottom line is a clear split. The legal deadline is a known event with a fixed outcome. The business catalysts-the guidance and the earnings-are the wild cards that will move the stock. For now, the tactical play is to watch for any validation of the "challenging setup" narrative. If management confirms the high-teens growth path, it could begin to rebuild confidence. If it falls short, the stock's deep discount may not be enough to stop the bleeding.